Pivotal Scientific Limited (PSL) is pleased to announce its assistance in the sale of Hungarian based Biotechnology company SCICONS to Nordic MUbio based in the Netherlands. Both are part of the ever growing PSL Alliance network, and we were able to connect Nordic-MUbio with SCICONS to create a partnership that provides value to both companies.
We supported Nordic Mubio throughout its acquisition of Scicons by identifying the target, negotiating the price, and managing the entire process up to the final sale. Our comprehensive support ensured a smooth transaction, from initial identification through to the successful completion of the acquisition.
This acquisition will broaden Nordic-MUbio product portfolio, with SICONS’ highly cited monoclonal antibodies which are used by researchers worldwide as a reliable tool for dsRNA detection.
“Companies are reaching out to us regularly when looking to Merge, Acquire or wanting to investigate management buyouts. SCICONS reached out and we were able to find a suitable buyer very quickly for them. A great addition to Nordic-MUbio’s portfolio”
Tim Bernard, CEO, Pivotal Scientific Limited
